Key Publications:
Prometastatic and Immunosuppressive Responses of the Tumor Microenvironment to Cytotoxic Chemotherapy:
[1] Karagiannis, G.S., Bianchi, A., Sanchez, L.R., Ambadipudi, K., Cui, M.H., Anampa, J.M., Asiry, S., Wang, Y., Harney, A.S., Pastoriza, J.M., Lin, Y., Chen, X., Jones, J.G., Entenberg, D., Haddad, D., Hodges, L.J., Duong, T.Q., Sparano, J.A., Oktay, M.H., Branch, C.A., Condeelis, J.S. Assessment of MRI to Estimate Metastatic Dissemination Risk and Prometastatic Effects of Chemotherapy. NPJ Breast Cancer, 2022; 8: 101.
[2] Asiry, S., Kim, G., Filippou, P.S., Rivera Sanchez, L., Entenberg, D., Marks, D.K., Oktay, M.H., Karagiannis, G.S. The Cancer Cell Dissemination Machinery as an Immunosuppressive Niche: A New Obstacle Towards the Era of Cancer Immunotherapy. Frontiers in Immunology, 2021; 12: 654877.
[3] Karagiannis, G.S., Condeelis, J.S., Oktay, M.H. Chemotherapy-Induced Metastasis: Molecular Mechanisms, Clinical Manifestations, Therapeutic Interventions. Cancer Research, 2019; 79: 4567-4576.
[4] Karagiannis, G.S., Pastoriza, J.M., Wang, Y., Harney, A.S., Entenberg, D., Pignatelli, J., Sharma, V.P., Xue, E.A., Cheng, E., D’Alfonso, T.M., Jones, J.G., Anampa, J., Rohan, T.E., Sparano, J.A., Condeelis, J.S., Oktay, M.H. Neoadjuvant Chemotherapy Induces Breast Cancer Metastasis through a TMEM-mediated Mechanism. Science Translational Medicine, 2017; 9: eaan0026.